Results 141 to 150 of about 27,928 (247)

Antibiotics in Veterinary Ophthalmology: Resistance, Stewardship, and Emerging Antibiotic‐Sparing Strategies

open access: yesVeterinary Ophthalmology, Volume 29, Issue 4, July 2026.
ABSTRACT Antimicrobial resistance (AMR) is a growing challenge in veterinary ophthalmology, particularly in cases of bacterial keratitis, where progressive stromal infection can threaten vision and globe integrity within hours to days. This review synthesizes current evidence on pathogen distribution, antimicrobial susceptibility profiles, multidrug ...
Lionel Sebbag, Oren Pe'er
wiley   +1 more source

Original Articles Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group [PDF]

open access: yes, 2011
Background Although the therapeutic outcome of acquired aplastic anemia has improved markedly with the introduction of immunosuppressive therapy using antithymocyte globulin and cyclosporine, a significant proportion of patients subsequently relapse and ...

core  

Outcomes of dengue infection in adults with underlying haematological diseases in Brazil during 2024 and 2025

open access: yes
British Journal of Haematology, Volume 209, Issue 1, Page 324-328, July 2026.
K. Tozatto‐Maio   +16 more
wiley   +1 more source

Antithyroid drug-induced aplastic anemia [PDF]

open access: yes, 2008
Background: Antithyroid drugs have been used for more than 50 years for the management of hyperthyroidism. Most patients tolerate treatment well but some may develop life threatening side effects such as agranulocytosis and aplastic anemia (AA).
Syriou, V.   +5 more
core  

Aplastic anemia - Diagnosis [PDF]

open access: yesDMW - Deutsche Medizinische Wochenschrift, 2003
K, Hohloch, L, Trümper, R, Schroers
openaire   +2 more sources

[Aplastic anemia and viral hepatitis (posthepatitic aplastic anemia)].

open access: yesTerapevticheskii arkhiv, 1999
To validate up-to-date policy of immunosuppressive therapy of patients with aplastic anemia (AA) which has developed either at acute or chronic phase of viral hepatitis.16 patients with AA detected within 6 months (9 patients) or 12-36 months (7 patients) after acute viral hepatitis received immunosuppressive therapy (antilymphocytic globulin ...
E A, Mikhaĭlova   +2 more
openaire   +1 more source

Cost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemia. [PDF]

open access: yesBlood Red Cells Iron
Ito S   +14 more
europepmc   +1 more source

Molecular alterations in the GATA-2, RUNX1, C/EBPα and hTERT genes in patients with aplastic anemia by MLPA. [PDF]

open access: yesGenet Mol Biol
Salas IM   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy